2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Recommendation of “Hold” from Brokerages

2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has received an average recommendation of “Hold” from the seven analysts that are presently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price objective among brokers […]

Leave a Reply

Your email address will not be published.

Previous post Badger Infrastructure Solutions Ltd. (TSE:BDGI) Receives Average Recommendation of “Moderate Buy” from Analysts
Next post Aeva Technologies, Inc. (NYSE:AEVA) Receives Consensus Recommendation of “Moderate Buy” from Analysts